{"nctId":"NCT02604173","briefTitle":"Altitude Sickness Prevention and Efficacy of Comparative Treatments","startDateStruct":{"date":"2016-08"},"conditions":["Acute Mountain Sickness"],"count":103,"armGroups":[{"label":"Budesonide","type":"EXPERIMENTAL","interventionNames":["Drug: Budesonide"]},{"label":"Acetazolamide","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Acetazolamide"]},{"label":"Control","type":"SHAM_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Budesonide","otherNames":["entocort, pulmicort"]},{"name":"Acetazolamide","otherNames":["Diamox"]},{"name":"Placebo","otherNames":["sugar pill"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Male and Female\n2. Sea level-dwelling hikers\n3. Between ages 18-65\n\nExclusion Criteria:\n\n1. History of allergy to acetazolamide or budesonide (or other corticosteroids)\n2. Taken NSAIDs, acetazolamide, or corticosteroids in the one week prior to study enrollment.\n3. Hazardous medical conditions which precludes the ability to moderately hike to high altitude including: sickle cell anemia, asthma, or COPD, severe anemia, or severe coronary arterial disease.\n4. Pregnancy or suspected pregnancy.\n5. Participants who are younger than 18 years of age and more than 65\n6. Sleep above 4'000 elevation in the preceding 1 week.\n7. History of asthma or COPD\n8. Current symptoms of an acute upper respiratory illness.\n9. Unable to complete a moderately strenuous hike at high altitude.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Acute Mountain Sickness","description":"Number of participants with acute mountain sickness (AMS) by Lake Lousie Questionnaire (LLQ)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"22","spread":null},{"groupId":"OG002","value":"15","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Severe Acute Mountain Sickness","description":"Number of participants with severe acute mountain sickness (AMS) by Lake Lousie Questionnaire (LLQ) (score \\> 5).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"11","spread":null},{"groupId":"OG002","value":"19","spread":null}]}]}]},{"type":"SECONDARY","title":"Oxygen Saturation","description":"measurement of oxygen saturation (%) by finger tip pulse oximeter.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"88.6","spread":"4.1"},{"groupId":"OG001","value":"88.1","spread":"3.8"},{"groupId":"OG002","value":"86.4","spread":"5"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":33},"commonTop":[]}}}